Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?
Reflections
Published
Volume 113, Issue 1, Pages 87–88
Authors:
Sushila Arya, M.D., Karl R. Hansen, M.D., Ph.D., Robert A. Wild, M.D., M.P.H., Ph.D.
Abstract:
Reflections on "Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial" by Li et al.
No comments yet.